program – text-test

9:00 a.m. – 9:30 a.m. Welcome & Continental Breakfast

9:30 a.m.     Keith Dionne, M.S. Technology and Public Policy, 1987 & PhD Chemical Engineering, 1989; CEO Luxa Biotechnology

Accomplishments of Professor Clark Colton


Enzyme Engineering*

9:40 a.m.     Bob Langer, ScD 1974, MIT, Institute Professor, MIT

From Nanotechnology to mRNA Vaccines: Overcoming Skepticism and Barriers to New Cancer Treatments and Global Health Solutions


Atherosclerosis

9:55 a.m.     Bob Bratzler, PhD 1974, Director, Director, Manistee Therapeutics, Director, Manistee Therapeutics

Atherosclerosis to Migraine: A Biotech Journey in Drug Development

10:10 a.m.     Jay Schnitzer, PhD in Chemical Engineering, 1973, M.D., from Harvard, 1973 (and HST, Harvard-MIT joint program)
Director, Frederick National Laboratory for Cancer Research; President, Leidos Biomedical Research, Inc.

A Life in the Hyphen: Tales from a Surgeon-Engineer

10:20 a.m.     George Truskey, PhD 1985, MIT

Life as a ChemE in BME

10:40 a.m. — Break

11:00 a.m.     Abdul Barakat, MS 1988, PhD 1994, MIT  ·  AXA Professor, École Polytechnique, France

Clark’s Impact on My Academic Career: From Atherosclerosis to Tick Marks on the Inside of Axes

11:15 a.m.     Nicholas Peppas

Biological Transport from 1975 to Now


Enzyme Engineering (continued)*

11:25 a.m.     Orn Adalsteinsson, MS 1974, PhD 1976, MIT, CEO, ICA

From ATP Synthesis to Immunotherapy: How Clark Colton Redefined the Chemical Engineer

11:35 a.m.     Andre Lamotte, ScD 1976,  Co-Founder and Vice Chairman, LowAlt Technologies AG (Switzerland)

Tribute to Clark Presented via video

11:45 a.m.     José Maria Costa Lafarga

My Pilgrimage from Science to Diplomacy (Pre-recorded)

11:55 a.m.     Georges Belfort

Friendship, Bioseparations and Tennis

12:00 p.m. — Lunch

1:00 p.m.     Kristala Prather, SB 1994, Course X, MIT, Arthur Dehon Little Professor & Department Head, MIT Chemical Engineering

Clark Colton and MIT ChemE


Membrane Processes

1:10 p.m.     Andrew Zydney, PhD 1985, MIT, Bayard D. Kunkle Chair and Professor of Chemical Engineering

My Journey in Membranes — and a Thank You to Clark

1:25 p.m.     Sujatha Karoor

A Journey from Dialysis to Rare Diseases

1:35 p.m.     Mike Pomianek

From the Colton Lab to a Life in the Law — Not as Big a Departure as You May Think


Immune Engineering, etc.

1:45 p.m.     Martin (Maish) Yarmush, PhD 1984, MIT, Paul and Mary Endowed Chair; Distinguished Professor of Biomedical Engineering, Rutgers University; Director, Center for Engineering in Medicine and Surgery, Mass General Brigham/Harvard Medical School

The Colton Effect: Science, People, and Lasting Influence


Diabetes

1:55 p.m.     Robert Hillman, SM 1978, MIT; PhD 2003, ETH-Zurich, Director, Center for Engineering in Medicine and Surgery, Mass General Brigham/Harvard Medical School

From Modeling Glucose and Insulin Pharmacodynamics to a Career in Drug Delivery, Medical Diagnostics and Drug Development (Presenting online)

2:05 p.m.     Keith Dionne

Oh, The Places You’ll Go!

2:10 p.m. — Break

2:25 p.m.     Susan Bonner-Weir, Senior Investigator, Joslin Diabetes Center / Professor of Medicine, Harvard Medical School

Oxygen Demands of Islets in Culture and After Transplantation

2:40 p.m.     Robert Johnson

A Time of Rapid Discovery in the Field of Encapsulated Cellular Transplantation

2:50 p.m.     Klearchos Papas

The Quest for a Functional Cure for Diabetes: The Colton/MIT Influence

3:05 p.m. — Break


Tumor-Targeted Drugs

3:20 p.m.     Kevin Brower, MS CEP 2006, PhD 2011, MIT, Global Head of Purification Development, Sanofi

A Short Walk from Building 66 to Genzyme Center and the Years Thereafter


Stem Cells

3:30 p.m.     Daryl Powers, PhD 2007, MIT Chemical Engineering, Director of MS&T, Bristol Myers Squibb

I Left Grad School and Got a Job

3:40 p.m.     Jeffry Millman, PhD 2011, MIT Chemical Engineering, Alan A. and Edith L. Wolff Professor of Endocrinology, Washington University School of Medicine

Stem Cell-Derived Islets for Type 1 Diabetes Cell Replacement Therapy

3:50 p.m.     Jit Hin Tan, SM CEP 2004, MBA 2013, PhD CEP 2013, MIT,  Senior Director, Strategic Initiatives – AI Transformation, CyberArk Software Ltd

Stochastic Gene Expression: My Random Career (So Far)


Concluding Remarks

4:00 p.m.     Rena Bizios

Clark Colton and the Biomedical Engineering Program at MIT

4:10 p.m.     Clark Colton

Reflections

4:20 p.m. — End of Symposium

The auditorium will remain open until 5:00 p.m.


*Research area of thesis